Related Experiment Video
Updated: Jun 27, 2025

The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Effects of selective serotonin reuptake inhibitors (SSRIs) on suicide: A network meta-analysis of double-blind
Yuling Li1, Chengfeng Chen1, Qinghua Chen1
1The Mental Health College of Guangzhou Medical University, Guangzhou, PR China; Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, PR China.
Abstract:
The relationship between the use of selective serotonin reuptake inhibitors (SSRIs) and suicide risk in patients with mental disorders remains controversial. We conducted a network meta-analysis to examine the effects of SSRIs on suicide risk in patients with mental disorders. A comprehensive search was conducted across PubMed, Web of Science, PsycINFO, CENTRAL, Wanfang Database, and China National Knowledge Infrastructure for articles published until December 19, 2023. The main outcomes were suicidal ideation and instances of suicidal behavior. We included 29 double-blind randomized trials in our analysis. The findings suggest that SSRIs primarily offer short-term protection against suicidal ideation. By week 2, paroxetine, fluoxetine, escitalopram, and non-SSRI treatments were linked to a decreased suicide risk compared with a placebo, with the exception of sertraline. This protective effect was diminished by week 8. In contrast, studies on instances of suicidal behavior from weeks 1 to 10 found no significant difference in efficacy between SSRIs, non-SSRIs, and placebo. These results indicate that SSRIs may offer short-term protection against suicidal ideation. However, their long-term effectiveness in mitigating suicidal ideation and preventing suicidal behaviors is limited.
Insights
Selective serotonin reuptake inhibitors (SSRIs) show short-term protection against suicidal thoughts in mental health patients. However, their long-term effectiveness in reducing suicidal ideation and behavior is limited.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Psychology
Background:
- The association between selective serotonin reuptake inhibitors (SSRIs) and suicide risk in individuals with mental disorders is a subject of ongoing debate.
- Understanding the precise impact of SSRIs on suicidal ideation and behavior is crucial for effective mental health treatment.
Purpose of the Study:
- To conduct a network meta-analysis evaluating the effects of SSRIs on suicide risk in patients diagnosed with mental disorders.
- To synthesize evidence from double-blind randomized trials to clarify the efficacy of SSRIs in managing suicidal ideation and behavior.
Main Methods:
- A comprehensive literature search was performed across major databases (PubMed, Web of Science, PsycINFO, CENTRAL, Wanfang, CNKI) up to December 19, 2023.
- Included 29 double-blind randomized trials focusing on suicidal ideation and suicidal behavior as primary outcomes.
- Network meta-analysis was employed to compare SSRIs, non-SSRIs, and placebo treatments.
Main Results:
- SSRIs demonstrated a short-term protective effect against suicidal ideation by week 2, with paroxetine, fluoxetine, and escitalopram showing significant risk reduction compared to placebo (sertraline was an exception).
- This protective effect on suicidal ideation diminished by week 8.
- No significant differences in efficacy were observed between SSRIs, non-SSRIs, and placebo for instances of suicidal behavior between weeks 1 and 10.
Conclusions:
- SSRIs may provide transient protection against suicidal ideation in patients with mental disorders.
- The long-term efficacy of SSRIs in mitigating suicidal ideation and preventing suicidal behaviors appears limited.
- Further research may be needed to explore alternative or adjunctive strategies for long-term suicide risk management in this population.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: Overview
G-protein Coupled Receptors
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Psychological and Sociocultural Causes of Schizophrenia

